Revealing the history and mystery of RNA-Seq A Gondane, HM Itkonen Current Issues in Molecular Biology 45 (3), 1860-1874, 2023 | 18 | 2023 |
Inhibition of CDK9 activity compromises global splicing in prostate cancer cells. IHM Hu Q, Poulose N, Girmay S, Helevä A, Doultsinos D, Gondane A, Steele RE ... RNA Biology, 2021 | 18 | 2021 |
Spatially conserved motifs in complement control protein domains determine functionality in regulators of complement activation-family proteins H Ojha, P Ghosh, H Singh Panwar, R Shende, A Gondane, SC Mande, ... Communications Biology 2 (1), 290, 2019 | 16 | 2019 |
O-GlcNAc transferase maintains metabolic homeostasis in response to CDK9 inhibition A Gondane, N Poulose, S Walker, IG Mills, HM Itkonen Glycobiology 32 (9), 751-759, 2022 | 9 | 2022 |
Castration-resistant prostate cancer cells are dependent on the high activity of CDK7 S Pallasaho, A Gondane, A Kuivalainen, S Girmay, S Moestue, M Loda, ... Journal of Cancer Research and Clinical Oncology 149 (8), 5255-5263, 2023 | 5 | 2023 |
Compromised CDK12 activity causes dependency on the non-essential spliceosome components S Pallasaho, A Gondane, D Duveau, C Thomas, M Loda, HM Itkonen bioRxiv, 2021.12. 07.470703, 2021 | 2 | 2021 |
CDK12‐inactivation‐induced MYC signaling causes dependency on the splicing kinase SRPK1 J Liang, A Gondane, HM Itkonen Molecular oncology, 2024 | 1 | 2024 |
CDK9 inhibition activates innate immune response through viral mimicry S Yalala, A Gondane, N Poulose, J Liang, IG Mills, HM Itkonen FASEB Journal 38 (8), e23628, 2024 | 1 | 2024 |
CDK9 inhibition activates innate immune response in prostate cancer cells S Yalala, A Gondane, N Poulose, J Liang, IG Mills, HM Itkonen Cancer Research 84 (6_Supplement), 528-528, 2024 | | 2024 |
O-GlcNAc transferase couples MRE11 to transcriptionally active chromatin to suppress DNA damage IHM Gondane A, Girmay S, Helevä A, Pallasaho S, Loda M | | 2022 |